Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M55,696Revenue (TTM) $M20,393Net Margin (%)12.0Altman Z-Score3.5
Enterprise Value $M60,449EPS (TTM) $1.6Operating Margin %13.6Piotroski F-Score5
P/E(ttm)23.4Beneish M-Score-2.4Pre-tax Margin (%)12.4Higher ROA y-yN
Price/Book2.810-y EBITDA Growth Rate %-2.0Quick Ratio1.2Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %-15.3Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow32.6y-y EBITDA Growth Rate %-6.5ROA % (ttm)5.8Higher Current Ratio y-yN
Dividend Yield %2.6PEG--ROE % (ttm)11.3Less Shares Outstanding y-yY
Payout Ratio %69.0Shares Outstanding M1,469ROIC % (ttm)72.3Gross Margin Increase y-yY

Gurus Latest Trades with ABT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTJoel Greenblatt 2016-03-31 Add0.35%$36.34 - $44.91
($39.68)
$ 37.91-4%Add 771.99%861,862
ABTGeorge Soros 2016-03-31 Reduce-0.2%$36.34 - $44.91
($39.68)
$ 37.91-4%Reduce -36.89%419,181
ABTRobert Olstein 2016-03-31 Add0.11%$36.34 - $44.91
($39.68)
$ 37.91-4%Add 9.45%220,000
ABTFirst Eagle Investment 2016-03-31 Add0.09%$36.34 - $44.91
($39.68)
$ 37.91-4%Add 12.53%7,507,515
ABTRichard Pzena 2016-03-31 Reduce-0.06%$36.34 - $44.91
($39.68)
$ 37.91-4%Reduce -4.50%4,642,170
ABTKen Fisher 2016-03-31 Reduce$36.34 - $44.91
($39.68)
$ 37.91-4%Reduce -10.84%15,413
ABTMario Gabelli 2016-03-31 Reduce$36.34 - $44.91
($39.68)
$ 37.91-4%Reduce -22.30%13,695
ABTDodge & Cox 2016-03-31 Reduce$36.34 - $44.91
($39.68)
$ 37.91-4%Reduce -3.30%29,268
ABTJoel Greenblatt 2015-12-31 Reduce-0.53%$39.89 - $46.05
($44.24)
$ 37.91-14%Reduce -93.21%98,838
ABTRobert Olstein 2015-12-31 Add0.15%$39.89 - $46.05
($44.24)
$ 37.91-14%Add 14.20%201,000
ABTRichard Pzena 2015-12-31 Reduce-0.08%$39.89 - $46.05
($44.24)
$ 37.91-14%Reduce -6.31%4,861,129
ABTVanguard Health Care Fund 2015-12-31 Reduce-0.08%$39.89 - $46.05
($44.24)
$ 37.91-14%Reduce -13.14%6,027,260
ABTGeorge Soros 2015-12-31 Reduce-0.05%$39.89 - $46.05
($44.24)
$ 37.91-14%Reduce -9.20%664,181
ABTFirst Eagle Investment 2015-12-31 Reduce-0.02%$39.89 - $46.05
($44.24)
$ 37.91-14%Reduce -2.26%6,671,344
ABTKen Fisher 2015-12-31 Add$39.89 - $46.05
($44.21)
$ 37.91-14%Add 13.32%17,286
ABTRichard Pzena 2015-09-30 Reduce-0.32%$39.06 - $51.2
($47.14)
$ 37.91-20%Reduce -18.17%5,188,346
ABTJoel Greenblatt 2015-09-30 Add0.16%$39.06 - $51.2
($47.14)
$ 37.91-20%Add 39.49%1,455,289
ABTRobert Olstein 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 37.91-20%Add 10.69%176,000
ABTFirst Eagle Investment 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 37.91-20%Add 15.36%6,825,289
ABTGeorge Soros 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 37.91-20%Add 21.47%731,481
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Watkin JaredSenior Vice President 2016-06-15Sell552$37.635.31view
YOOR BRIAN BSenior Vice President and CFO 2016-06-01Sell565$39.490.35view
NATH DEEPAK S.Senior Vice President 2016-04-28Sell53$41.31-4.07view
Contreras JaimeSenior Vice President 2016-03-31Sell462$41.78-5.15view
Salvadori Daniel Gesua SiveSenior Vice President 2016-02-29Sell881$39.260.94view
YOOR BRIAN BSenior Vice President and CFO 2016-02-29Sell865$39.121.3view
Mason Heather LExecutive Vice President 2016-02-29Sell3,032$39.270.92view
Funck Robert EVice President, Controller 2016-02-29Sell1,333$39.30.84view
Warmuth Michael JExecutive Vice President 2016-02-29Sell9,399$38.842.03view
Pavee Jean-YvesSenior Vice President 2016-02-29Sell1,665$39.240.99view

Quarterly/Annual Reports about ABT:

News about ABT:

Articles On GuruFocus.com
Opinions Differ on Abbott Deal to Acquire St. Jude's Medical Jun 18 2016 
This Health Care Dividend Aristocrat Will Profit From Old Age – Globally May 29 2016 
Ackman Selling Zoetis, But Other Firms Are Jumping In May 10 2016 
Bearish Sentiment in Becton Dickinson's Stock Apr 27 2016 
Stocks Murray Stahl Bought for Past 2 Quarters Apr 26 2016 
A Cheap Dividend Aristocrat Yielding Over 4% Mar 02 2016 
Valeant's Share Price Continues to Decline Feb 05 2016 
Abbott a Dividend Aristocrat Stock Propelled by Emerging Markets Dec 11 2015 
Baxalta Vs. AbbVie: Biopharma Spin-Off Battle Aug 20 2015 
Profit from Emerging Market Health Care Growth With Abbott Laboratories Jul 25 2015 

More From Other Websites
'Mad Money' Lightning Round: Intel Is Just Treading Water Jun 23 2016
Abbott Laboratories : ABT-US: Dividend Analysis : July 15th, 2016 : By the numbers : June 23, 2016 Jun 22 2016
Cramer: Without business from Apple, it's treading water Jun 22 2016
Abbott Hosts Conference Call for Second-Quarter Earnings Jun 22 2016
How Waltham's PerkinElmer became the world leader in newborn screening Jun 21 2016
Abbott Labs upgraded by Edward Jones Jun 21 2016
Epizyme Offers Early Data on Non-Hodgkin Lymphoma Drug Jun 20 2016
Opinions Differ on Abbott Deal to Acquire St. Jude's Medical Jun 18 2016
Abbott Laboratories (ABT) Is in Oversold Territory: What's Next? Jun 17 2016
Why M&A Deals Can Strengthen Moats Jun 16 2016
Abbott Labs (ABT) Reports Positive Data on FreeStyle Libre Jun 14 2016
Abbott Laboratories (ABT) Stock Down, Jefferies Raises Price Target Jun 14 2016
Abbott Announces Positive Results from Groundbreaking Study of FreeStyle® Libre System for People... Jun 13 2016
Former Fed President: All My Very Rich Friends Are Holding a Lot of Cash Jun 13 2016
Abbott Declares 370th Consecutive Quarterly Dividend Jun 10 2016
7 Medical Stocks to Buy with Market-Beating Yields Jun 09 2016
Exelixis Up on Positive Kidney Cancer Data on Cabometyx Jun 07 2016
No Easy Way Out for Abbott as Deal Target Faces Bribery Probe Jun 02 2016
Abbott Says It’s Auditing Alere Books; Got Partial Response Jun 01 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)